Bravecto Spot-On for Dogs

Product description

INDICATIONS
For the treatment and prevention of tick, flea and mite infestations in dogs and cats.
Bravecto® Spot-On can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of mange caused by Demodex spp. and Sarcoptes scabiei mites in dogs. For the treatment of Otodectes spp. mite infestations in dogs and cats.
In cats, Bravecto® Spot-On provides immediate and persistent flea and tick killing activity for 3 months.
In dogs, Bravecto® Spot-On provides immediate and persistent tick killing activity for 4 months and flea killing activity for 6 months. Bravecto® Spot-On is well tolerated in MDR1 dogs.

COMPOSITION
Each 1 mℓ of Bravecto® Spot-On contains 280 mg fluralaner.
Each pipette delivers:
Miniature dogs: 112,5 mg fluralaner Small cats: 112,5 mg fluralaner
Small dogs: 250 mg fluralaner Medium cats: 250 mg fluralaner
Medium dogs: 500 mg fluralaner Large cats: 500 mg fluralaner
Large dogs: 1 000 mg fluralaner
Extra-large dogs: 1 400 mg fluralaner

EFFICACY
Bravecto® Spot-On was shown to be effective against ticks, fleas and mites.
It is a systemic insecticide and acaricide.
Cats: the product provides immediate and persistent flea and tick killing activity for 3 months.
Dogs: the product provides immediate and persistent tick killing activity for 4 months and flea activity for 6 months.
Ticks and fleas must attach to the host and commence feeding in order to be exposed to the active substance. The onset of effect is within 8 hours.